TrialmBio2023
Early antibody treatment, inflammation, and risk of post-COVID conditions.
Kelly A Gebo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled ittrialcites it
TrialmBio2023
Kelly A Gebo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.